BuybackJul 7, 2026, 04:31 PM
Lakefront Biotherapeutics Repurchases 104,022 Shares for €2.73M
AI Summary
Lakefront Biotherapeutics NV announced the repurchase of 104,022 of its own shares between June 29, 2026, and July 3, 2026, as part of a program initiated on June 9, 2026. The total value of these repurchases amounted to €2,730,010.70, with an average price of €26.24 per share. Following these transactions, the company holds 303,756 of its own ordinary shares as of market close on July 3, 2026.
Key Highlights
- Repurchased 104,022 shares between June 29, 2026, and July 3, 2026.
- Total value of shares repurchased was €2,730,010.70.
- Average price paid per share was €26.24.
- Lowest price paid was €25.60, highest was €26.88.
- As of July 3, 2026, Lakefront Biotherapeutics holds 303,756 of its own ordinary shares.
Price Impact
More from GLPG